P21 resists ferroptosis in osteoarthritic chondrocytes by regulating GPX4 protein stability
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved..
Ferroptosis is involved in the pathogenesis of osteoarthritis (OA) while suppression of chondrocyte ferroptosis has a beneficial effect on OA. However, the molecular mechanism of ferroptosis in OA remains to be elucidated. P21, an indicator of aging, has been reported to inhibit ferroptosis, but the relationship between P21 and ferroptosis in OA remains unclear. Here, we aimed to investigate the expression and function of P21 in OA chondrocytes, and the involvement of P21 in the regulation of ferroptosis in chondrocytes. First, we demonstrated that high P21 expression was observed in the cartilage from OA patients and destabilized medial meniscus (DMM) mice, and in osteoarthritic chondrocytes induced by IL-1β, FAC and erastin. P21 knockdown exacerbated the reduction of Col2a1 and promoted the upregulation of MMP13 in osteoarthritic chondrocytes. Meanwhile, P21 knockdown exacerbated cartilage degradation in DMM-induced OA mouse models and decreased GPX4 expression in vivo. Furthermore, P21 knockdown sensitized chondrocytes to ferroptosis induced by erastin, which was closely associated with the accumulation of lipid peroxides. In mechanism, we demonstrated that P21 regulated the stability of GPX4 protein, and the regulation was independent of NRF2. Meanwhile, we found that P21 significantly affected the recruitment of GPX4 to linear ubiquitin chain assembly complex (LUBAC) and regulated the level of M1-linked ubiquitination of GPX4. Overall, our results suggest that P21 plays an essential anti-ferroptosis role in OA by regulating the stability of GPX4.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:212 |
|---|---|
| Enthalten in: |
Free radical biology & medicine - 212(2024) vom: 20. Feb., Seite 336-348 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zheng, Zehang [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 24.01.2024 Date Revised 18.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.freeradbiomed.2023.12.047 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366670905 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366670905 | ||
| 003 | DE-627 | ||
| 005 | 20240218231923.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.freeradbiomed.2023.12.047 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1298.xml |
| 035 | |a (DE-627)NLM366670905 | ||
| 035 | |a (NLM)38176476 | ||
| 035 | |a (PII)S0891-5849(23)01209-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zheng, Zehang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a P21 resists ferroptosis in osteoarthritic chondrocytes by regulating GPX4 protein stability |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.01.2024 | ||
| 500 | |a Date Revised 18.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Ferroptosis is involved in the pathogenesis of osteoarthritis (OA) while suppression of chondrocyte ferroptosis has a beneficial effect on OA. However, the molecular mechanism of ferroptosis in OA remains to be elucidated. P21, an indicator of aging, has been reported to inhibit ferroptosis, but the relationship between P21 and ferroptosis in OA remains unclear. Here, we aimed to investigate the expression and function of P21 in OA chondrocytes, and the involvement of P21 in the regulation of ferroptosis in chondrocytes. First, we demonstrated that high P21 expression was observed in the cartilage from OA patients and destabilized medial meniscus (DMM) mice, and in osteoarthritic chondrocytes induced by IL-1β, FAC and erastin. P21 knockdown exacerbated the reduction of Col2a1 and promoted the upregulation of MMP13 in osteoarthritic chondrocytes. Meanwhile, P21 knockdown exacerbated cartilage degradation in DMM-induced OA mouse models and decreased GPX4 expression in vivo. Furthermore, P21 knockdown sensitized chondrocytes to ferroptosis induced by erastin, which was closely associated with the accumulation of lipid peroxides. In mechanism, we demonstrated that P21 regulated the stability of GPX4 protein, and the regulation was independent of NRF2. Meanwhile, we found that P21 significantly affected the recruitment of GPX4 to linear ubiquitin chain assembly complex (LUBAC) and regulated the level of M1-linked ubiquitination of GPX4. Overall, our results suggest that P21 plays an essential anti-ferroptosis role in OA by regulating the stability of GPX4 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a (Bortezomib, PubChem CID: 387447) | |
| 650 | 4 | |a (PubChem CID: 11214940) | |
| 650 | 4 | |a (Tert-Butylhydroquinone, PubChem CID: 16043) | |
| 650 | 4 | |a (Z-Leu-leu-leu-al, PubChem CID: 462382) | |
| 650 | 4 | |a (cycloheximide, PubChem CID: 6197) | |
| 650 | 4 | |a (ferric ammonium citrate, PubChem CID: 14457) | |
| 650 | 4 | |a CHX | |
| 650 | 4 | |a Erastin | |
| 650 | 4 | |a FAC | |
| 650 | 4 | |a Ferroptosis | |
| 650 | 4 | |a GPX4 | |
| 650 | 4 | |a M1-linked ubiquitination | |
| 650 | 4 | |a MG132 | |
| 650 | 4 | |a Osteoarthritis | |
| 650 | 4 | |a P21 | |
| 650 | 4 | |a PS341 | |
| 650 | 4 | |a TBHQ | |
| 700 | 1 | |a Shang, Xingru |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Kai |e verfasserin |4 aut | |
| 700 | 1 | |a Hou, Yanjun |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Xiong |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Jingting |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Haigang |e verfasserin |4 aut | |
| 700 | 1 | |a Ruan, Zhaoxuan |e verfasserin |4 aut | |
| 700 | 1 | |a Hou, Liangcai |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Zhou |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Genchun |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Fei |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Fengjing |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Free radical biology & medicine |d 1989 |g 212(2024) vom: 20. Feb., Seite 336-348 |w (DE-627)NLM012613827 |x 1873-4596 |7 nnns |
| 773 | 1 | 8 | |g volume:212 |g year:2024 |g day:20 |g month:02 |g pages:336-348 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.freeradbiomed.2023.12.047 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 212 |j 2024 |b 20 |c 02 |h 336-348 | ||